Evidence map›Paper›PMID 40187784›Full record

ReviewBMJ open2025

Framework to guide the use of mathematical modelling in evidence-based policy decision-making.

Jacquie Oliwa, Fatuma Hassan Guleid, Collins J Owek, Justinah Maluni, Juliet Jepkosgei, Jacinta Nzinga, Vincent O Were, So Yoon Sim, Abel W Walekhwa, Hannah Clapham and 6 more

Abstract readReview
In one paragraph

Review in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. The Risk from Reopening International Travel During a Disease X Pandemic: A Case Study of SARS-CoV-2.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jacquie OliwaHealth Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya joliwa@kemri-wellcome.org.ORCID http://orcid.org/0000-0002-4575-2447
Fatuma Hassan GuleidHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya.ORCID http://orcid.org/0000-0002-8103-8136
Collins J OwekDepartment of Public and Global Health, University of Nairobi, Nairobi, Kenya.
Justinah MaluniHealth Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Juliet JepkosgeiHealth Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Jacinta NzingaHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme Nairobi, Nairobi, Kenya.
Vincent O WereData Synergy and Evaluation Unit, African Population and Health Research Center, Nairobi, Kenya.
So Yoon SimWorld Health Organization, Geneva, Switzerland.
Abel W WalekhwaDiseases Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Hannah ClaphamNational University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-2531-161X
Saudamini DabakHealth Intervention and Technology Assessment Program, Muang, Nonthaburi, Thailand.ORCID http://orcid.org/0000-0001-6161-6165
Sarin KcHealth Intervention and Technology Assessment Program, Muang, Nonthaburi, Thailand.ORCID http://orcid.org/0000-0002-3972-946X
Liza HadleyDisease Dynamics Unit, University of Cambridge, Cambridge, UK.
Eduardo UndurragaPontificia Universidad Catolica de Chile, Santiago, Chile.
Brittany L HagedornBill & Melinda Gates Foundation, Seattle, Washington, USA.
Raymond Cw HutubessyWorld Health Organization, Geneva, Switzerland.

Funding

Gates Foundation INV-034291Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

introductionThe COVID-19 pandemic highlighted the significance of mathematical modelling in decision-making and the limited capacity in many low-income and middle-income countries (LMICs). Thus, we studied how modelling supported policy decision-making processes in LMICs during the pandemic (details in a separate paper).We found that strong researcher-policymaker relationships and co-creation facilitated knowledge translation, while scepticism, political pressures and demand for quick outputs were barriers. We also noted that routine use of modelled evidence for decision-making requires sustained funding, capacity building for policy-facing modelling, robust data infrastructure and dedicated knowledge translation mechanisms.These lessons helped us co-create a framework and policy roadmap for improving the routine use of modelling evidence in public health decision-making. This communication paper describes the framework components and provides an implementation approach and evidence for the recommendations. The components include (1) funding, (2) capacity building, (3) data infrastructure, (4) knowledge translation platforms and (5) a culture of evidence use. KEY ARGUMENTS: Our framework integrates the supply (modellers) and demand (policymakers) sides and contextual factors that enable change. It is designed to be generic and disease-agnostic for any policy decision-making that modelling could support. It is not a decision-making tool but a guiding framework to help build capacity for evidence-based policy decision-making. The target audience is modellers and policymakers, but it could include other partners and implementers in public health decision-making.

conclusionThe framework was created through engagements with policymakers and researchers and reflects their real-life experiences during the COVID-19 pandemic. Its purpose is to guide stakeholders, especially in lower-resourced settings, in building modelling capacity, prioritising efforts and creating an enabling environment for using models as part of the evidence base to inform public health decision-making. To validate its robustness and impact, further work is needed to implement and evaluate this framework in diverse settings.

Indexed as

COVID-19Decision MakingHealth PolicyModels, TheoreticalPolicy MakingCapacity BuildingDeveloping CountriesEvidence-Based MedicineHumansPandemicsPublic HealthSARS-CoV-2Translational Research, BiomedicalCOVID-19Decision MakingHealth policy

Identifiers

PMID40187784
PMCPMC11973756

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.